Clinical Trial Update: Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

The PTMA Device trial aiming to reduce mitral regurgitation in patients with heart failure (Phase 2/Phase 3) has been suspended; no safety or efficacy results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Regurgitation

Drugs mentioned

• PTMA Device

Snippet

Sponsor: Viacor | Conditions: Mitral Regurgitation, Heart Failure | Phase 2, Phase 3 | Status: SUSPENDED